Company intelligence / Profile preview

Panpharma

Luitré-Dompierre, Bretagne, Francepanpharma.eu ↗

Ownership: Private
Employees: ~550
Development stage: Commercial

Overview

Panpharma specializes in developing, producing, and marketing injectable generic medicines for hospitals and clinics. It has a strong focus on antibiotic therapy and maintains one of the largest portfolios of injectable antibiotics produced in France. The company operates globally across more than 75 countries with manufacturing sites in France and Germany. No clinical trial results are reported as it focuses on generics rather than novel therapeutics.

Therapeutic areas: OtherNeurologyInfectious Diseases
Modalities: Small molecules (injectable generics such as antibiotics, anesthetics, analgesics)
Industry: Biotech

Drug pipeline

1 asset

heparin

Commercial

Indications: Anticoagulation

Beyond the preview

Go deeper on Panpharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Panpharma.

Explore the full profile